Valentina Guarneri

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 34

Top Venues

NPJ breast cancer

The oncologist

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

University of Padua

University of Modena and Reggio Emilia (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Padua Oct 01 2014

Italy

Associate Professor :: Dipartimento di Scienze Chirurgiche, Oncologiche e Gastroenterologiche

Istituto Oncologico Veneto Sep 01 2013

Italy

Head of the Traslational Research and Innovative Therapy Unit :: Oncologia 2

University of Padua Apr 01 2014 - Sep 30 2014

Italy

Assistant Professor :: Dipartimento di Scienze Chirurgiche, Oncologiche e Gastroenterologiche

University of Modena and Reggio Emilia - Mar 31 2013

Italy

Coordinator of the Breast Unit :: Division of Medical Oncology

University of Modena and Reggio Emilia - Mar 31 2013

Italy

Assistant Professor :: Division of Medical Oncology

University of Texas MD Anderson Cancer Center

United States

Visiting Assistant Professor :: Dept. of Breast Medical Oncology

University of Texas MD Anderson Cancer Center

United States

Observer :: Dept. of Breast Medical Oncology

University of Modena and Reggio Emilia

Italy

Attending Physician :: Division of Oncology

Education History

University of Modena and Reggio Emilia

Italy

PHD

University of Pisa

Italy

PHD

Publications

Michele Bottosso, Federica Miglietta, Grazia Maria Vernaci, Tommaso Giarratano, Maria Vittoria Dieci, Valentina Guarneri, Gaia Griguolo
Gene-expression assays to tailor adjuvant endocrine therapy for HR+/HER2- breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Giulia Pasello, Martina Lorenzi, Daniela Scattolin, Alessandro Del Conte, Fabiana Cecere, Alberto Pavan, Marianna Macerelli, Valentina Polo, Sara Pilotto, Mariacarmela Santarpia, Enrico Cumerlato, Valentina Da Ros, Giada Targato, Alberto Bortolami, Laura Bonanno, Alessandra Ferro, Alessandro Dal Maso, Stefano Frega, Valentina Guarneri
Osimertinib in Patients With Treatment-Naive EGFR-Mutant Non-small Cell Lung Cancer: Overall Survival, Post-progression Management and Budget Impact Analysis in Real-World. The oncologist 29 (7) (2024)
Giulia Pasello, Martina Lorenzi, Daniela Scattolin, Alessandro Del Conte, Fabiana Cecere, Alberto Pavan, Marianna Macerelli, Valentina Polo, Sara Pilotto, Mariacarmela Santarpia, Enrico Cumerlato, Valentina Da Ros, Giada Targato, Alberto Bortolami, Laura Bonanno, Alessandra Ferro, Alessandro Dal Maso, Stefano Frega, Valentina Guarneri
Osimertinib in Patients With Treatment-Naive EGFR-Mutant Non-small Cell Lung Cancer: Overall Survival, Post-progression Management and Budget Impact Analysis in Real-World. The oncologist 29 (7) (2024)
Michele Bottosso, Federica Miglietta, Grazia Maria Vernaci, Tommaso Giarratano, Maria Vittoria Dieci, Valentina Guarneri, Gaia Griguolo
Gene Expression Assays to Tailor Adjuvant Endocrine Therapy for HR+/HER2- Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
PierFranco Conte, Valentina Guarneri, Roberto D'Amico
Reply to M. Kusumoto et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Michele Bottosso, Federica Miglietta, Grazia Maria Vernaci, Tommaso Giarratano, Maria Vittoria Dieci, Valentina Guarneri, Gaia Griguolo
Gene Expression Assays to Tailor Adjuvant Endocrine Therapy for HR+/HER2- Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Michele Bottosso, Federica Miglietta, Grazia Maria Vernaci, Tommaso Giarratano, Maria Vittoria Dieci, Valentina Guarneri, Gaia Griguolo
Gene Expression Assays to Tailor Adjuvant Endocrine Therapy for HR+/HER2- Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
PierFranco Conte, Valentina Guarneri, Roberto D'Amico
Reply to M. Kusumoto et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Michele Bottosso, Benjamin Verret, Olivier Caron, Nadim Hamzaoui, Éric Pasmant, François-Xavier Danlos, Pascaline Boudou-Rouquette, Arunya Srikaran, Hélène Blons, Valentina Guarneri, Sherene Loi, Fabrice Andre, Camille Tlemsani
Efficacy and Safety of Immune Checkpoint Blockade in Patients With Li-Fraumeni Syndrome. JCO precision oncology 8 (2024)
Giulia Pasello, Martina Lorenzi, Daniela Scattolin, Alessandro Del Conte, Fabiana Cecere, Alberto Pavan, Marianna Macerelli, Valentina Polo, Sara Pilotto, Mariacarmela Santarpia, Enrico Cumerlato, Valentina Da Ros, Giada Targato, Alberto Bortolami, Laura Bonanno, Alessandra Ferro, Alessandro Dal Maso, Stefano Frega, Valentina Guarneri
Osimertinib in Patients With Treatment-Naive EGFR-Mutant Non-small Cell Lung Cancer: Overall Survival, Post-progression Management and Budget Impact Analysis in Real-World. The oncologist 29 (7) (2024)
PierFranco Conte, Valentina Guarneri, Roberto D'Amico
Reply to M. Kusumoto et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Giulia Pasello, Martina Lorenzi, Daniela Scattolin, Alessandro Del Conte, Fabiana Cecere, Alberto Pavan, Marianna Macerelli, Valentina Polo, Sara Pilotto, Mariacarmela Santarpia, Enrico Cumerlato, Valentina Da Ros, Giada Targato, Alberto Bortolami, Laura Bonanno, Alessandra Ferro, Alessandro Dal Maso, Stefano Frega, Valentina Guarneri
Osimertinib in Patients With Treatment-Naive EGFR-Mutant Non-small Cell Lung Cancer: Overall Survival, Post-progression Management and Budget Impact Analysis in Real-World. The oncologist (2024)
Matthew P Goetz, Irfan Cicin, Laura Testa, Sara M Tolaney, Jens Huober, Valentina Guarneri, Stephen R D Johnston, Miguel Martin, Priya Rastogi, Nadia Harbeck, Ashwin Shahir, Ran Wei, Valérie André, Hope S Rugo, Joyce O'Shaughnessy
Impact of dose reductions on adjuvant abemaciclib efficacy for patients with high-risk early breast cancer: analyses from the monarchE study. NPJ breast cancer 10 (1) (2024)
Matthew P Goetz, Irfan Cicin, Laura Testa, Sara M Tolaney, Jens Huober, Valentina Guarneri, Stephen R D Johnston, Miguel Martin, Priya Rastogi, Nadia Harbeck, Ashwin Shahir, Ran Wei, Valérie André, Hope S Rugo, Joyce O'Shaughnessy
Impact of dose reductions on adjuvant abemaciclib efficacy for patients with high-risk early breast cancer: analyses from the monarchE study. NPJ breast cancer 10 (1) (2024)
Grazia Maria Vernaci, Edoardo Vincenzo Savarino, Ilaria Patuzzi, Sonia Facchin, Fabiana Zingone, Davide Massa, Giovanni Faggioni, Tommaso Giarratano, Federica Miglietta, Gaia Griguolo, Angelo Paolo Dei Tos, Marcello Lo Mele, Elisa Gasparini, Giancarlo Bisagni, Valentina Guarneri, Maria Vittoria Dieci
Characterization of Gut Microbiome Composition in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy. The oncologist (2023)
Marion T van Mackelenbergh, Sibylle Loibl, Michael Untch, Marc E Buyse, Charles E Geyer, Luca Gianni, Andreas Schneeweiß, PierFranco Conte, Martine J Piccart, Hervé R Bonnefoi, Christian Jackisch, Valentina Nekljudova, Gong Tang, Pinuccia Valagussa, Colin Neate, Richard D Gelber, Coralie Poncet, Pierre Squifflet, Everardo Delforge Saad, Dominik Heinzmann, Carsten Denkert, Priya Rastogi, Javier Cortes, Valentina Guarneri, Evandro de Azambuja, David A Cameron, Gustavo Ismael, Norman Wolmark, Patricia Cortazar
Pathologic Complete Response and Individual Patient Prognosis After Neoadjuvant Chemotherapy Plus Anti-Human Epidermal Growth Factor Receptor 2 Therapy of Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Maria Vittoria Dieci, Giancarlo Bisagni, Stefania Bartolini, Antonio Frassoldati, Roberto Vicini, Sara Balduzzi, Roberto D'amico, Pierfranco Conte, Valentina Guarneri
Type of adjuvant endocrine therapy and disease-free survival in patients with early HR-positive/HER2-positive BC: analysis from the phase III randomized ShortHER trial. NPJ breast cancer 9 (1) (2023)
Federica Miglietta, Moira Ragazzi, Bethania Fernades, Gaia Griguolo, Davide Massa, Fabio Girardi, Michele Bottosso, Alessandra Bisagni, Giovanni Zarrilli, Francesca Porra, Daniela Iannaccone, Leocadia Dore, Mariangela Gaudio, Giacomo Santandrea, Angelo Paolo Dei Tos, Marcello Lo Mele, Rita De Sanctis, Alberto Zambelli, Giancarlo Bisagni, Valentina Guarneri, Maria Vittoria Dieci
A prognostic model based on residual cancer burden and tumor-infiltrating lymphocytes on residual disease after neoadjuvant therapy in HER2+ breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Maria Vittoria Dieci, Giancarlo Bisagni, Stefania Bartolini, Antonio Frassoldati, Roberto Vicini, Sara Balduzzi, Roberto D'amico, Pierfranco Conte, Valentina Guarneri
Author Correction: Type of adjuvant endocrine therapy and disease-free survival in patients with early HR-positive/HER2-positive BC: analysis from the phase III randomized ShortHER trial. NPJ breast cancer 9 (1) (2023)
Fabio Girardi, Sabrina Marini, Francesca Porra, Sonia Carpentieri, Alberto Marchet, Tania Saibene, Marcello Lo Mele, Tommaso Giarratano, Carlo Alberto Giorgi, Eleonora Mioranza, Cristina Falci, Giovanni Faggioni, Francesca Caumo, Gaia Griguolo, Maria Vittoria Dieci, Valentina Guarneri
The Impact of COVID19 on Treatment Practices for Patients With Early Breast Cancer: A Cross-Sectional Study From a Large Cancer Center In Italy. The oncologist (2023)
Maria Vittoria Dieci, Giancarlo Bisagni, Stefania Bartolini, Antonio Frassoldati, Roberto Vicini, Sara Balduzzi, Roberto D'amico, Pierfranco Conte, Valentina Guarneri
Type of adjuvant endocrine therapy and disease-free survival in patients with early HR-positive/HER2-positive BC: analysis from the phase III randomized ShortHER trial. NPJ breast cancer 9 (1) (2023)
Pierre Squifflet, Everardo Delforge Saad, Sibylle Loibl, Marion T van Mackelenbergh, Michael Untch, Priya Rastogi, Luca Gianni, Andreas Schneeweiß, PierFranco Conte, Martine J Piccart, Hervé R Bonnefoi, Christian Jackisch, Valentina Nekljudova, Gong Tang, Pinuccia Valagussa, Colin Neate, Richard D Gelber, Coralie Poncet, Dominik Heinzmann, Carsten Denkert, Charles E Geyer, Javier Cortes, Valentina Guarneri, Evandro de Azambuja, David A Cameron, Gustavo Ismael, Norman Wolmark, Patricia Cortazar, Marc E Buyse, null null
Re-Evaluation of Pathologic Complete Response as a Surrogate for Event-Free and Overall Survival in Human Epidermal Growth Factor Receptor 2-Positive, Early Breast Cancer Treated With Neoadjuvant Therapy Including Anti-Human Epidermal Growth Factor Receptor 2 Therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Emma Zattarin, Daniele Presti, Luigi Mariani, Caterina Sposetti, Rita Leporati, Alice Menichetti, Chiara Corti, Chiara Benvenuti, Giovanni Fucà, Riccardo Lobefaro, Francesca Ligorio, Leonardo Provenzano, Andrea Vingiani, Marta Del Vecchio, Gaia Griguolo, Marianna Sirico, Ottavia Bernocchi, Antonio Marra, Paola Zagami, Elisa Agostinetto, Flavia Jacobs, Pierluigi di Mauro, Andrea Esposito, Carlo Alberto Giorgi, Luca Lalli, Laura Boldrini, Pier Paolo Berton Giacchetti, Ambra Carnevale Schianca, Valentina Guarneri, Rebecca Pedersini, Agnese Losurdo, Alberto Zambelli, Daniele Generali, Carmen Criscitiello, Curigliano Giuseppe, Giancarlo Pruneri, Filippo de Braud, Maria Vittoria Dieci, Claudio Vernieri
Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors. NPJ breast cancer 9 (1) (2023)
Maria Vittoria Dieci, Giancarlo Bisagni, Stefania Bartolini, Antonio Frassoldati, Roberto Vicini, Sara Balduzzi, Roberto D'amico, Pierfranco Conte, Valentina Guarneri
Type of adjuvant endocrine therapy and disease-free survival in patients with early HR-positive/HER2-positive BC: analysis from the phase III randomized ShortHER trial. NPJ breast cancer 9 (1) (2023)
Laura Bonanno, Martina Lorenzi, Davide Massa, Mattia De Nuzzo, Valentina Angerilli, Fabiana Zingone, Brigida Barberio, Alberto Russi, Fabio Girardi, Alessandra Ferro, Alessandro Dal Maso, Stefano Frega, Giulia Pasello, Angelo Paolo Dei Tos, Marina Coppola, Angelo Paolo Dei Tos, Edoardo Vincenzo Savarino, Valentina Guarneri
Immune-Related Diarrhea and Colitis in Non-small Cell Lung Cancers: Impact of Multidisciplinary Management in a Real-World Setting. The oncologist (2023)
PierFranco Conte, Giancarlo Bisagni, Federico Piacentini, Samanta Sarti, Santino Minichillo, Elisa Anselmi, Michele Aieta, Vittorio Gebbia, Alessio Schirone, Antonino Musolino, Ornella Garrone, Alessandra Beano, Anita Rimanti, Francesco Giotta, Anna Turletti, Federica Miglietta, Maria Vittoria Dieci, Roberto Vicini, Sara Balduzzi, Roberto D'Amico, Valentina Guarneri
Nine-Week Versus One-Year Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 10-Year Update of the ShortHER Phase III Randomized Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Federica Miglietta, Gaia Griguolo, Michele Bottosso, Tommaso Giarratano, Marcello Lo Mele, Angelo Paolo Dei Tos, Matilde Cacciatore, Elisa Genovesi, Debora De Bartolo, Grazia Maria Vernaci, Ottavia Amato, Francesca Porra, PierFranco Conte, Valentina Guarneri, Maria Vittoria Dieci
HER2-low-positive breast cancer: evolution from primary tumor to residual disease after neoadjuvant treatment. NPJ breast cancer 8 (1) (2022)
Maria Vittoria Dieci, Gaia Griguolo, Michele Bottosso, Vassilena Tsvetkova, Carlo Alberto Giorgi, Grazia Maria Vernaci, Silvia Michieletto, Silvia Angelini, Alberto Marchet, Giulia Tasca, Elisa Genovesi, Enrico Cumerlato, Marcello Lo Mele, PierFranco Conte, Valentina Guarneri
Impact of estrogen receptor levels on outcome in non-metastatic triple negative breast cancer patients treated with neoadjuvant/adjuvant chemotherapy. NPJ breast cancer 7 (1) (2021)
Federica Miglietta, Gaia Griguolo, Michele Bottosso, Tommaso Giarratano, Marcello Lo Mele, Angelo Paolo Dei Tos, Matilde Cacciatore, Elisa Genovesi, Debora De Bartolo, Grazia Maria Vernaci, Ottavia Amato, PierFranco Conte, Valentina Guarneri, Maria Vittoria Dieci
Evolution of HER2-low expression from primary to recurrent breast cancer. NPJ breast cancer 7 (1) (2021)
Federica Miglietta, Gaia Griguolo, Michele Bottosso, Tommaso Giarratano, Marcello Lo Mele, Angelo Paolo Dei Tos, Matilde Cacciatore, Elisa Genovesi, Debora De Bartolo, Grazia Maria Vernaci, Ottavia Amato, PierFranco Conte, Valentina Guarneri, Maria Vittoria Dieci
Author Correction: Evolution of HER2-low expression from primary to recurrent breast cancer. NPJ breast cancer 7 (1) (2021)
Alessandra Buja, Giulia Pasello, Giuseppe De Luca, Alberto Bortolami, Manuel Zorzi, Federico Rea, Carlo Pinato, Antonella Dal Cin, De Polo Anna, Marco Schiavon, Andrea Zuin, Marco Marchetti, Giovanna Scroccaro, Vincenzo Baldo, Massimo Rugge, Valentina Guarneri, PierFranco Conte
Non-Small-Cell Lung Cancer: Real-World Cost Consequence Analysis. JCO oncology practice 17 (8) (2021)
Alessandro Dal Maso, Martina Lorenzi, Alessandra Ferro, Sara Pilotto, Fabiana Cecere, Alessandro Follador, Valentina Polo, Alessandro Del Conte, Giulia Sartori, Marco Giavarra, Daniela Scattolin, Stefano Indraccolo, Stefano Frega, Giovanna De Maglio, Jessica Menis, Laura Bonanno, Fiorella Calabrese, Valentina Guarneri, PierFranco Conte, Giulia Pasello
Real-world data on treatment outcomes in EGFR-mutant non-small-cell lung cancer patients receiving osimertinib in second or further lines. Future oncology (London, England) 17 (19) (2021)
Federica Miglietta, Maria Silvia Cona, Maria Vittoria Dieci, Valentina Guarneri, Nicla La Verde
An overview of immune checkpoint inhibitors in breast cancer. Exploration of targeted anti-tumor therapy 1 (6) (2020)
Tommaso Giarratano, Simona Frezzini, Monica Zanocco, Carlo Alberto Giorgi, Eleonora Mioranza, Federica Miglietta, Gaia Griguolo, Cristina Falci, Giovanni Faggioni, Giulia Tasca, Elisabetta Di Liso, Grazia Maria Vernaci, Alice Menichetti, Mara Mantiero, Daniela Grosso, Valentina Guarneri, Maria Vittoria Dieci
Use of scalp cooling device to prevent alopecia for early breast cancer patients receiving chemotherapy: A prospective study. The breast journal 26 (7) (2019)

Valentina Guarneri.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Valentina Guarneri